Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The effect of tumour necrosis factor (TNF alpha) antibodies on synovial cell interleukin-1 (IL-1) production was investigated in 7 patients with rheumatoid arthritis and in 7 with osteoarthritis. Synovial cell IL-1 production was significantly reduced by anti-TNF alpha antibody in cultures from patients with rheumatoid arthritis, but antilymphotoxin antibody did not have this effect (except in 1 culture). In cultures from patients with osteoarthritis spontaneous IL-1 production was low, despite high concentrations of TNF alpha, and IL-1 production was not inhibited by anti-TNF alpha antibody. In rheumatoid arthritis, TNF alpha may be the main inducer of IL-1, and anti-TNF alpha agents may be useful in treatment.

Original publication

DOI

10.1016/s0140-6736(89)90430-3

Type

Journal article

Journal

Lancet

Publication Date

29/07/1989

Volume

2

Pages

244 - 247

Keywords

Adult, Aged, Aged, 80 and over, Antilymphocyte Serum, Arthritis, Rheumatoid, Cells, Cultured, Enzyme-Linked Immunosorbent Assay, Female, Humans, Immune Sera, Interleukin-1, Male, Middle Aged, Osteoarthritis, Synovial Membrane, Tumor Necrosis Factor-alpha